Data from a new study elucidates the role of a transcriptional enhancer dubbed HAR123 in neural cell development and cognitive flexibility.

Researchers say work lays the foundation for a first-line, deployable antiviral platform that is virus agnostic and modular.

Antimicrobial resistance studies often focus on individual protein variants, neglecting broader protein family dynamics. Dihydrofolate reductase (DHFR), a key antibiotic target, has been extensively ...

The current $195 million investment is part of a commitment to invest more than $10 billion for innovation and manufacturing capacity enhancement.

The basal ganglia in rats uses separate codes for learned movements and “natural” behaviors, offering insights into human ...

Model serves as platform for understanding how chronic inflammation related to alcohol consumption accelerates pancreatic cancer development.

AIs are as much a tool as a hammer or shovel, but to find the opportunities, we need to understand what the realities and risks are.

Knocking down EPIC1 sensitized triple negative breast tumor-bearing mice to immunotherapy with the PD-1 inhibitor pembrolizumab.

Bayer will partner with Kumquat Biosciences to develop Kumquat’s KRAS G12D inhibitor, which could generate $1.3 billion-plus for the San Diego biotech.

Sarepta Therapeutics said Friday that the deaths of two patients taking its marketed gene therapy Elevidys® (delandistrogene ...

An oxygen-generating implant keeps high-density insulin-producing cells alive in diabetic rats for months without immune suppression.

The enhanced hybrid model improves the predictive capability of data-driven modeling and reduces the need for process knowledge.